News

In the latest issue of Rock Talk, NIH’s Janine Austin Clayton, M.D., Associate Director for Research on Women’s Health and the Director of the NIH Office of Research on Women’s Health, shares the results of a Request for Information (RFI) that was released a year ago to gather feedback about a policy for requiring a deliberate approach to the consideration of sex as a biological variable (SABV) in preclinical research. The NIH Office of Research on Women’s Health and the NIH Office of Extramural Research, in response to information gathered from the RFI, are working hard to develop SABV training resources and scientific tools that will enable researchers to be prepared for the forthcoming policy. To read more about the plan in developing SABV policy in preclinical research, click here.